Skip to main content

Table 1 Diffuse large B cell lymphoma (DLBCL) patient characteristics

From: 5-Hydroxymethylcytosine profiles of cfDNA are highly predictive of R-CHOP treatment response in diffuse large B cell lymphoma patients

Characteristics

Level/type

Value

n

 

86

Sex (%)

F

40 (46.5)

M

46 (53.5)

Age (mean (SD))

 

54.59 (15.56)

Diagnosis (%)

DLBCL

86 (100.0)

Therapy (%)

R-CHOP

86 (100.0)

Response (%)

CR

32 (37.2)

PD

15 (17.4)

PR

25 (29.1)

SD

14 (16.3)

Ann Arbor stage (%)

I

6 (7.0)

II

18 (20.9)

III

7 (8.1)

IV

48 (55.8)

Unknown

7 (8.1)

Cell of origin (%)

GCB

23 (26.7)

Non-GCB

61 (70.9)

Unknown

2 (2.3)

IPI (%)

0

8 (9.3)

1

12 (14.0)

2

18 (20.9)

3

28 (32.6)

4

15 (17.4)

5

2 (2.3)

Unknown

3 (3.5)

Mean LDH (SD)

 

364.33 (326.72)

Mean β2MG (SD)

 

2.84 (2.77)

  1. IPI, International Prognostic Index; GCB, germinal center B cell; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; LDH, lactate dehydrogenase; β2MG, beta2 microglobulin; WBC, white blood cell